Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Oncolytic adenovirus coding for shedding-resistant MICA enhances immune responses against tumors ; volume:73 ; number:1 ; day:5 ; month:1 ; year:2024 ; pages:1-10 ; date:1.2024
Cancer immunology immunotherapy ; 73, Heft 1 (5.1.2024), 1-10, 1.2024
- Urheber
-
Costa-Garcia, M.
Rojas, JJ
Ramos, MD
Barlabé, P.
Calvo, P.
Navas, J.
Alemany, R.
Moreno, R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03611-3
- URN
-
urn:nbn:de:101:1-2404190751478.356525418290
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Costa-Garcia, M.
- Rojas, JJ
- Ramos, MD
- Barlabé, P.
- Calvo, P.
- Navas, J.
- Alemany, R.
- Moreno, R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Immune checkpoint modulation enhances oncolytic virotherapy
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Mica.
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Immune checkpoint modulation enhances oncolytic virotherapy
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies
Mica.
HSF1 overexpression enhances oncolytic effect of replicative adenovirus
Interferon-α enhances antitumor activities of oncolytic adenovirus-mediated IL-24 expression in hepatocellular carcinoma
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Immune checkpoint modulation enhances oncolytic virotherapy
Establishing Suspension Cell Cultures for Improved Manufacturing of Oncolytic Adenovirus
Targeting the Retinoblastoma/E2F repressive complex by CDK4/6 inhibitors amplifies oncolytic potency of an oncolytic adenovirus
Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
Acetylcholinesterase overexpression mediated by oncolytic adenovirus exhibited potent anti-tumor effect
Effects of pre-existing anti-adenovirus antibodies on transgene expression levels and therapeutic efficacies of arming oncolytic adenovirus
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies